Navigation Links
Medarex Announces Allowance of Investigational New Drug Applications for Wholly Owned Fully Human Anti-CD19 Antibody, MDX-1342
Date:12/4/2007

Two Separate Clinical Studies Planned for Cancer and Inflammatory Disease

PRINCETON, N.J., Dec. 4 /PRNewswire-FirstCall/ -- Medarex, Inc. (Nasdaq: MEDX) announced today the allowance of two separate investigational new drug applications (IND) filed with the U.S. Food & Drug Administration (FDA) for MDX-1342, one for the treatment of chronic lymphocytic leukemia (CLL) and the other for rheumatoid arthritis. MDX-1342 is a fully human antibody that targets CD19, a molecule specifically expressed on normal B-cells and malignant B-cells in diseases such as CLL, acute lymphoblastic leukemia, follicular non-Hodgkins lymphoma, diffuse large B-cell lymphoma and mantle cell lymphoma.

The IND for the treatment of CLL is for an open-label, multi-dose, dose-escalation Phase I clinical trial for cancer that is expected to enroll up to 52 patients with relapsed or refractory CLL. This trial is designed to establish and evaluate the safety, tolerability and maximum tolerated dose, as well as preliminary pharmacodynamics and efficacy of MDX-1342.

The IND for the treatment of rheumatoid arthritis is for a randomized, single-dose, dose-escalation, placebo-controlled Phase I clinical trial that is expected to enroll up to 90 patients with rheumatoid arthritis. This trial is designed to evaluate the safety and tolerability profile of MDX-1342 and to determine the dose range for B-cell depletion.

"We are pleased with the advancement of a new product candidate from Medarex's proprietary pipeline into clinical trials," said Howard H. Pien, President and CEO of Medarex. "We look forward to the continued development of MDX-1342, which could provide new treatment options for a number of serious conditions."

About
'/>"/>

SOURCE Medarex, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)... YORK, Nov. 30 Reportlinker.com an...able in its catalogue: ,, Decubitus Ulcer Trea... http://www.reportlinker.com/p0164283/Decubitus-Ul....html ,, Decubitus Ulcers are lesions resulti...of the patient,s bodyweight. Pressure ulcer treatm...
(Date:11/30/2009)... Ill., Nov. 30 The Simmons law fir...ted to representing thousands of women that were s...pular birth control pill manufactured and marketed... Panel on Multidistrict Litigation has ordered tha...wsuits be consolidated and centralized for pretria...
(Date:11/30/2009)...O, Nov. 30 Minimally-invasive proc... surgery, particularly in oncology, cardiology and...t for image-guided navigation expected to reach $6...dvantages offered by minimally-invasive procedures...r patient comfort and faster patient throughput. ...
Breaking Medicine Technology:Reportlinker Adds Decubitus Ulcer Treatment Products - A Worldwide Market Review 2Reportlinker Adds Decubitus Ulcer Treatment Products - A Worldwide Market Review 3Reportlinker Adds Decubitus Ulcer Treatment Products - A Worldwide Market Review 4Reportlinker Adds Decubitus Ulcer Treatment Products - A Worldwide Market Review 5Reportlinker Adds Decubitus Ulcer Treatment Products - A Worldwide Market Review 6Simmons Firm's Partner Trent Miracle Chosen to Help Lead National Litigation Against Bayer 2Philips Showcases Interventional Radiology Solutions to Support Growing Need For Minimally-Invasive Procedures 2Philips Showcases Interventional Radiology Solutions to Support Growing Need For Minimally-Invasive Procedures 3Philips Showcases Interventional Radiology Solutions to Support Growing Need For Minimally-Invasive Procedures 4Philips Showcases Interventional Radiology Solutions to Support Growing Need For Minimally-Invasive Procedures 5Genome duplication responsible for more plant species than previously thought 9552 1Genome duplication responsible for more plant species than previously thought 9552 2Genome duplication responsible for more plant species than previously thought 9552 3New insights into limb formation 9549 1New insights into limb formation 9549 2Turners Utilization of BIM and Lean Construction on Middle Tennessee Medical Center in Murfreesboro Tenn to Save Project Millions of Dollars 54356 1Turners Utilization of BIM and Lean Construction on Middle Tennessee Medical Center in Murfreesboro Tenn to Save Project Millions of Dollars 54356 2
... Medical,Corporation (OTC BB: CONX) and the Compan...ata demonstrating a significant correlation,betwee...M),bio-markers and cardiovascular disease. The dat...national Society on Thrombosis and,Hemostasis (IST...k shows the association of antibodies to,the Ather...
... Adjusted Weight,Loss; Obesity Program to be Disco...Call/ -- Manhattan,Pharmaceuticals, Inc. today ann...cal trials of oral Oleoyl-estrone (OE). The result...lled studies, one,in common obesity and the other ...r clinically meaningful placebo adjusted weight lo...
Other Medicine Technology:Corgenix Reports New Clinical Data Correlating AtherOx Technology,With Vascular Disease 2Corgenix Reports New Clinical Data Correlating AtherOx Technology,With Vascular Disease 3Corgenix Reports New Clinical Data Correlating AtherOx Technology,With Vascular Disease 4Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for,Oral Oleoyl-estrone 2Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for,Oral Oleoyl-estrone 3Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for,Oral Oleoyl-estrone 4
(Date:11/30/2009)...ease by 247%, - Net loss reduced significantly... - CRH Medical Corporation (CRM:TSX-V) announced t...hs ended September 30, 2009 (all figures are in US...ber 30, 2009, the Company reported a net loss of $... three months ended September 30, 2008, an improve...
(Date:11/30/2009)...ire-USNewswire/ -- At a briefing of the Leadership...sortium for Citizens with Disabilities (CCD) today...nd Advocacy for NCOA, called on Congress to ensure...he growing crisis in long-term care for older Amer...rs, after working hard all their lives, are being ...
(Date:11/30/2009)...wire/ -- Kool Smiles received top honors for its...nition as one of InfoWorld ,s Top 100 IT Proje...rk Blomquist, Kool Smiles built a Wyse-based thin-...alth records systems at 13 new dental offices acro...lete, Kool Smiles has implemented electronic healt...
(Date:11/30/2009)...from over. Every year, almost three million peopl...om AIDS-related diseases." ,, WASHINGTON, Nov....009 the Global AIDS Alliance (GAA) calls on Presid...t alarming reports from the World Health Organizat... to be of catastrophic proportion, affecting shock...
(Date:11/30/2009)...re/ -- Major League Baseball,s Mark Teahen, long...recently acquired by the Chicago White Sox, will r...given annually to a Major League Baseball player w...ion of baseball great Fred Hutchinson, both on and... Calif., native made his MLB debut with the Royals...
Breaking Medicine News(10 mins):Health News:CRH Medical reports Q3 2009 results 2Health News:CRH Medical reports Q3 2009 results 3Health News:NCOA, Bedlin Brief Leading Aging Organizations on Health Care Reform, Needed Long-Term Care Provisions 2Health News:Kool Smiles Named Among 2009 InfoWorld 100 2Health News:GAA Calls on President Obama to Act on the Reality of AIDS 2Health News:GAA Calls on President Obama to Act on the Reality of AIDS 3Health News:Mark Teahen Named 2009 Hutch Award Winner 2
... April 28 Genomic,Health, Inc. (Nasdaq: GHDX ) t...lth,s Chairman and Chief Executive Officer, will p...lugged Conference in Key Biscayne, FL,on May 2, 20...mic Health,s,website at http://investor.genomiche...
...rystal Research Associates, LLC,announced today th...ew(R),(EIO(R)) on Advaxis, Inc. (OTC Bulletin Boar... http://www.crystalra.com ., Advaxis, Inc. ("Adva...sponses against cancer as well as infectious,and i...
... information provider offers real estate community...vapor intrusion, MILFORD, Conn., April 28 Enviro.... provider of environmental risk information,servi... with vapor intrusion. The poll also showed that e...
...hen Company,s Military Logistics and Health Care ...SDA, Md., April 28 Lockheed Martin,Corporation (N...t to acquire,Atlanta, Georgia based Eagle Group In...t of the agreement, the parties have agreed to exc...
...ight as they conceive, raising complication risks,...Day News) -- The number of women starting their pr...ed since 1999, but rates of gestational diabetes h...f teenagers who had diabetes before birth jumped f...
...ho attend day care or play groups have about a 30%...childhood leukaemia than those who do not, accordi...link. , The new research, to be presented Tuesda... investigating the association between social cont...
Other Medicine News:Health News:Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Advaxis, Inc. 2Health News:Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Advaxis, Inc. 3Health News:EDR Poll Finds Environmental Professionals, Property Buyers and Lenders Eager to Apply New Vapor Intrusion Standard During Real Estate Transactions to Protect Health and Investments 2Health News:EDR Poll Finds Environmental Professionals, Property Buyers and Lenders Eager to Apply New Vapor Intrusion Standard During Real Estate Transactions to Protect Health and Investments 3Health News:Lockheed Martin Agrees to Acquire Eagle Group International, LLC 2Health News:Lockheed Martin Agrees to Acquire Eagle Group International, LLC 3Health News:Pre-Pregnancy Diabetes Rates Have Doubled 2Health News:Pre-Pregnancy Diabetes Rates Have Doubled 3Health News:New analysis finds daycare attendance early in life cuts childhood leukemia risk by 30 percent 2Health News:New analysis finds daycare attendance early in life cuts childhood leukemia risk by 30 percent 3
The Hacker HCM4000 Automatic CoverSlipping Machine
...OptiEdge offers design innovations that ensure out... stability, and excellent handling. The biostable ...orts of vacuoles; the patented OptiEdge is designe...360 degrees of contact with the posterior capsule;...
Single Piece PMMA Lens
Single Piece PMMA Lens with Suture Holes
Medicine Products: